Keyphrases
Lung Transplantation
100%
Lung
34%
Chronic Obstructive Pulmonary Disease
26%
Macrophages
16%
Interleukin-13 (IL-13)
16%
Interleukin-33 (IL-33)
13%
Lung Disease
13%
Transplantation
13%
Positron Emission Tomography
13%
Airway Epithelial Cells
13%
Primary Graft Dysfunction
13%
Clinical Outcomes
13%
Chronic Airways Disease
12%
Respiratory Viral Infection
12%
Bronchoalveolar Lavage
12%
Lung Donor
12%
Post-viral
11%
Confidence Interval
11%
Donor Lung
11%
Asthma
11%
Sendai Virus
10%
Mucus Production
10%
Chronic Lung Allograft Dysfunction
9%
Allocation Policy
9%
Antibody-mediated Rejection
9%
Alveolar Macrophages
9%
Airway Disease
9%
Size Matching
8%
Innate Immune Response
8%
Lung Tissue
8%
Endotoxin
8%
Lung Allocation
8%
Lung Macrophages
8%
Lung Inflammation
7%
Chronic Lung Disease
7%
Pulmonary Fibrosis
7%
COVID-19
7%
Immunosuppression
7%
Bronchiolitis Obliterans Syndrome
7%
H2-M3
6%
Airway mucus
6%
Epithelial Progenitor Cells
6%
Donor-specific Antibodies
6%
Mouse Model
6%
Clinical Features
6%
Antithymocyte Globulin
6%
Explanted Lungs
6%
Viral Infection
6%
Belatacept
5%
Allosensitization
5%
Medicine and Dentistry
Lung Transplantation
97%
Lung
70%
Chronic Obstructive Pulmonary Disease
22%
Epithelial Cell
17%
Transplantation
15%
Macrophage
14%
Positron Emission Tomography
13%
Primary Graft Dysfunction
12%
Silo-Filler's Disease
12%
Lung Lavage
11%
Disease
10%
Pulmonary Fibrosis
10%
Antibody Mediated Rejection
9%
Bronchiolitis Obliterans
9%
Computer Assisted Tomography
8%
Immunocompetent Cell
8%
Infection
8%
Pneumonia
8%
Progenitor Cell
8%
Allograft
8%
Interleukin-33
7%
Immunity
7%
Respiratory Disease
6%
Endotoxin
6%
COVID-19
6%
Idiopathic Pulmonary Fibrosis
6%
Health Care Cost
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Antibodies
6%
Clinical Feature
5%
Volumetry
5%
Chemokine Receptor
5%
Acute Graft Versus Host Disease
5%
Carbon 11
5%
Alveolar Macrophage
5%
Donor Management
5%
Chronic Airway Disease
5%
Cohort Analysis
5%
Immunosuppressive Treatment
5%
Cytokine
5%
Volunteer
5%
Immunology and Microbiology
Lung Transplantation
59%
Macrophage
27%
Viral Disease
20%
Alveolar Macrophage
16%
Positron Emission Tomography
14%
Allograft
13%
Immunity
12%
Asthma
11%
Interleukin-33
10%
Antibody Mediated Rejection
9%
Pulmonary Inflammation
9%
Sendai Virus
9%
Interleukin 13
9%
Myeloid
8%
Mouse Model
7%
Acute Graft Rejection
7%
Immunosuppression
7%
Antibodies
7%
Normal Human
6%
COVID-19
6%
Anti-Thymocyte Globulin
6%
CCR2
6%
Acute Graft Versus Host Disease
5%
Chemokine Receptor
5%
Computer Assisted Tomography
5%
Belatacept
5%
Immune Response
5%
Respiratory Virus
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Innate Immune System
5%
Epitope
5%
Influenza
5%
Blood Plasma
5%
Cytokine
5%
Bronchiolitis
5%
